KV Pharmaceutical Co. (NYSE: KV-A) voluntarily suspended shipments of all drugs in tablet form and recalled a production lot of its pain management medication Hydromorphone. The stock price skidded $2.68 to close at $2.71.
KV Pharmaceutical Suspends Shipments
December 23, 2008 at 18:20 PM EST